Sarcopenia and Myosteatosis as Prognostic Markers in Patients with Advanced Cholangiocarcinoma Undergoing Palliative Treatment

Background: Cholangiocarcinoma (CCA) represents the second most common primary liver cancer and is characterized by a very poor outcome, but reliable prognostic markers are largely missing. Sarcopenia, the progressive loss of muscle mass and strength, as well as myosteatosis have been associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Jördens, Markus S., Wittig, Linda, Heinrichs, Lisa, Keitel, Verena, Schulze-Hagen, Maximilian, Antoch, Gerald, Knoefel, Wolfram T., Fluegen, Georg, Luedde, Tom, Loberg, Christina, Roderburg, Christoph, Loosen, Sven H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509694/
https://www.ncbi.nlm.nih.gov/pubmed/34640358
http://dx.doi.org/10.3390/jcm10194340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509694/
https://www.ncbi.nlm.nih.gov/pubmed/34640358
http://dx.doi.org/10.3390/jcm10194340

Ejemplares similares